dtc
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Shawna Williams | Mar 28, 2018
An analysis of 49 patient samples finds high proportions of false positives and misinterpretation.
Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
Opinion: Get to Know Why People Openly Share Genomic Data
Opinion: Get to Know Why People Openly Share Genomic Data
Tobias Haeusermann | May 9, 2017
It’s not only about health but also about exploring ancestry and contributing to science.